Phase I dose-escalation study of afatinib, an ErbB family blocker, plus docetaxel in patients with advanced cancer
Marshall, John, Shapiro, Geoffrey I, Uttenreuther-Fischer, Martina, Ould-Kaci, Mahmoud, Stopfer, Peter, Gordon, Michael SVolume:
9
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon.12.195
Date:
February, 2013
File:
PDF, 609 KB
english, 2013